OMX Stockholm Pharmaceuticals a SX201030GI Indice
7223.68 SEK
{{ price }}
0.079886%
{{change_pct}}%
PAYS
États-Unis
Marché
Nasdaq GIDS
Plus Haut - Plus Bas [24H]
7223.68
-
7223.68 SEK
Nombre de composants
32
OMX Stockholm Pharmaceuticals a Graphique des prix
Top 5 Gagnants au Cours des Dernières 24 Heures
| ORX.ST | Orexo AB (publ) | +12.8% | |
|---|---|---|---|
| BONEX.ST | Bonesupport Holding AB (publ) | +4.84% | |
| ACE.ST | Ascelia Pharma AB (publ) | +4.07% | |
| MVIR.ST | Medivir AB (publ) | +2.82% | |
| MCAP.ST | MedCap AB (publ) | +2.56% |
Top 5 Perdants au Cours des Dernières 24 Heures
| ACTI.ST | Active Biotech AB (publ) | -18.97% | |
|---|---|---|---|
| CANTA.ST | Cantargia AB (publ) | -6.88% | |
| ATORX.ST | Alligator Bioscience AB (publ) | -5.06% | |
| XBRANE.ST | Xbrane Biopharma AB (publ) | -4.03% | |
| IMMU.ST | Mendus AB (publ) | -3.45% |
OMX Stockholm Pharmaceuticals a SX201030GI APERÇU FINANCIER ET COMMERCIAL
| OMX Stockholm Pharmaceuticals a Prix de l'Indice | 7223.68 SEK |
| Dernière clôture | N/A |
| Ouverture | N/A |
| Offre | N/A x N/A |
| Demande | N/A x N/A |
| Variation du jour | N/A |
| Plage sur 52 semaines | N/A |
| Volume | N/A |
| Volume moyen | N/A |
Informations de trading
OMX Stockholm Pharmaceuticals a Historique des prix de l'Indice
| Plus haut sur 52 semaines | N/A |
| Plus bas sur 52 semaines | N/A |
| Moyenne mobile sur 50 jours | N/A |
| Moyenne mobile sur 200 jours | N/A |
SX201030GI Statistiques de l'indice
| Volume moyen (3 mois) | N/A |
| Volume journalier moyen (10 jours) | N/A |
Questions et réponses concernant l'indice OMX Stockholm Pharmaceuticals a
Quel est le cours actuel de l'Indice SX201030GI ?
Le prix de l'Indice OMX Stockholm Pharmaceuticals a SX201030GI aujourd'hui est de 7223.68 SEK.
Comment acheter l'Indice OMX Stockholm Pharmaceuticals a ?
Vous pouvez acheter l'indice SX201030GI sur la plateforme Nasdaq GIDS. Contactez votre conseiller financier pour choisir un courtier.
Quel est le symbole boursier de l'Indice OMX Stockholm Pharmaceuticals a ?
Le symbole boursier ou ticker de l'Indice OMX Stockholm Pharmaceuticals a est SX201030GI.
Combien de composants contient l'Indice OMX Stockholm Pharmaceuticals a ?
L'Indice OMX Stockholm Pharmaceuticals a contient 32 composants.
À quel pays appartient l'Indice OMX Stockholm Pharmaceuticals a ?
L'Indice OMX Stockholm Pharmaceuticals a fait référence à United States.
À quelle bourse appartient l'Indice OMX Stockholm Pharmaceuticals a ?
L'Indice OMX Stockholm Pharmaceuticals a fait référence à la bourse Nasdaq GIDS.
OMX Stockholm Pharmaceuticals a COMPOSANTS
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Swedish Orphan Biovitrum AB (publ) SOBI.ST | $307.2 29.99 USD |
+0.92
|
$105.51B 10.3B USD | $224.36K 21.9K USD | $301.6 29.44 USD | $307.2 29.99 USD | $105.51B 10.3B USD | 26.87 | $11.43 1.12 USD |
| Camurus AB (publ) CAMX.ST | $638.5 62.33 USD |
-0.62
|
$37.44B 3.65B USD | $135.25K 13.2K USD | $626 61.11 USD | $641 62.57 USD | $37.44B 3.65B USD | 69.47 | $9.19 0.9 USD |
| BioArctic AB (publ) BIOA-B.ST | $201.2 19.64 USD |
+0.5
|
$17.81B 1.74B USD | $155.59K 15.19K USD | $198 19.33 USD | $202 19.72 USD | $17.81B 1.74B USD | 19.76 | $10.18 0.99 USD |
| Bonesupport Holding AB (publ) BONEX.ST | $268.4 26.2 USD |
+4.84
|
$17.68B 1.73B USD | $319.99K 31.23K USD | $253.4 24.73 USD | $270 26.36 USD | $17.68B 1.73B USD | 145.08 | $1.85 0.18 USD |
| Biotage AB (publ) BIOT.ST | $142.4 13.9 USD |
+0.07
|
$11.4B 1.11B USD | $1.77M 172.4K USD | $141.7 13.83 USD | $143.8 14.04 USD | $11.4B 1.11B USD | 44.77 | $3.18 0.31 USD |
| Calliditas Therapeutics AB (publ) CALTX.ST | $208 20.3 USD |
0
|
$11.24B 1.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.24B 1.1B USD | 0 | $0 0 USD |
| BioGaia AB (publ) BIOG-B.ST | $103.3 10.08 USD |
+0.49
|
$10.45B 1.02B USD | $90.74K 8.86K USD | $102.6 10.02 USD | $104.3 10.18 USD | $10.45B 1.02B USD | 33.75 | $3.06 0.3 USD |
| MedCap AB (publ) MCAP.ST | $441 43.05 USD |
+2.56
|
$6.59B 643.15M USD | $11.31K 1.1K USD | $425 41.49 USD | $444.5 43.39 USD | $6.59B 643.15M USD | 32.47 | $13.58 1.33 USD |
| Probi AB (publ) PROB.ST | $348 33.97 USD |
0
|
$3.97B 387.05M USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.97B 387.05M USD | 0 | $0 0 USD |
| BioInvent International AB (publ) BINV.ST | $38.1 3.72 USD |
+0.79
|
$2.51B 244.73M USD | $86.9K 8.48K USD | $36.75 3.59 USD | $38.7 3.78 USD | $2.51B 244.73M USD | 0 | -$7.12 -0.6 USD |
| Vicore Pharma Holding AB (publ) VICO.ST | $9.35 0.91 USD |
-1.48
|
$2.19B 214.09M USD | $277.69K 27.11K USD | $9.32 0.91 USD | $9.71 0.95 USD | $2.19B 214.09M USD | 0 | -$1.99 -0.1 USD |
| Hansa Biopharma AB (publ) HNSA.ST | $24.2 2.36 USD |
-0.74
|
$1.59B 154.98M USD | $81.68K 7.97K USD | $23.8 2.32 USD | $24.52 2.39 USD | $1.59B 154.98M USD | 0 | -$9.25 -0.9 USD |
| Egetis Therapeutics AB (publ) EGTX.ST | $3.93 0.38 USD |
-2.96
|
$1.41B 137.81M USD | $862.04K 84.15K USD | $3.89 0.38 USD | $4.21 0.41 USD | $1.41B 137.81M USD | 0 | -$1 -0.09 USD |
| Saniona AB (publ) SANION.ST | $9.3 0.91 USD |
-3.23
|
$1.27B 123.54M USD | $695.83K 67.92K USD | $9.05 0.88 USD | $9.72 0.95 USD | $1.27B 123.54M USD | 4.65 | $2 0.2 USD |
| Xspray Pharma AB (publ) XSPRAY.ST | $31.3 3.06 USD |
0
|
$1.16B 113.47M USD | $11.81K 1.15K USD | $30.9 3.02 USD | $32.2 3.14 USD | $1.16B 113.47M USD | 0 | -$7.59 -0.7 USD |
| SynAct Pharma AB SYNACT.ST | $18.72 1.83 USD |
+0.11
|
$917.45M 89.55M USD | $176.86K 17.26K USD | $18.5 1.81 USD | $19.18 1.87 USD | $917.45M 89.55M USD | 0 | -$1.89 -0.1 USD |
| Infant Bacterial Therapeutics AB (publ) IBT-B.ST | $58.1 5.67 USD |
+0.69
|
$782.69M 76.4M USD | $12.19K 1.19K USD | $57.9 5.65 USD | $60 5.86 USD | $782.69M 76.4M USD | 0 | -$9.34 -0.9 USD |
| Abliva AB (publ) ABLI.ST | $0.44 0.04 USD |
0
|
$715.67M 69.86M USD | $0 0 USD | $0 0 USD | $0 0 USD | $715.67M 69.86M USD | 0 | $0 0 USD |
| Orexo AB (publ) ORX.ST | $18.5 1.81 USD |
+12.8
|
$638.35M 62.31M USD | $91.47K 8.93K USD | $16.52 1.61 USD | $21 2.05 USD | $638.35M 62.31M USD | 0 | -$6.09 -0.5 USD |
| Ascelia Pharma AB (publ) ACE.ST | $4.86 0.47 USD |
+4.07
|
$466.59M 45.55M USD | $1.36M 133.02K USD | $4.55 0.44 USD | $4.9 0.48 USD | $466.59M 45.55M USD | 0 | -$1.22 -0.1 USD |
- {{ link.label }} {{link}}